Accelerated by global health demands, vaccine development & immunotechnology focuses on engineering immune-based solutions that protect against infectious diseases and chronic conditions. This field brings together antigen design, adjuvant innovation, and delivery platform development—ranging from recombinant proteins and viral vectors to mRNA technologies. Cutting-edge immunotechnology supports the creation of more stable, targeted, and long-lasting vaccines, while nanotechnology and liposomal carriers enhance delivery efficiency. In addition, bioinformatics tools are aiding epitope prediction and immune profiling. Vaccine Development & Immunotechnology also contributes to therapeutic vaccines against cancer, autoimmune disorders, and allergies. As rapid-response vaccine platforms become more robust, this area remains critical for ensuring global health preparedness, equitable distribution, and next-generation immunization strategies.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain